Copyright
©The Author(s) 2024.
World J Clin Cases. Mar 26, 2024; 12(9): 1585-1596
Published online Mar 26, 2024. doi: 10.12998/wjcc.v12.i9.1585
Published online Mar 26, 2024. doi: 10.12998/wjcc.v12.i9.1585
n | Mean | SD | Mean rank | χ2 | df | P value | ||
Right | Preoperative | 4 | 20.00 | 6.06 | 5.50 | 17.414 | 5 | 0.004 |
Postoperative 1-wk | 4 | 19.75 | 6.02 | 5.13 | ||||
Postoperative 1-month | 4 | 19.00 | 5.48 | 3.88 | ||||
Postoperative 2-month | 4 | 18.25 | 5.74 | 2.75 | ||||
Postoperative 4-month | 4 | 17.75 | 5.25 | 1.88 | ||||
Postoperative 1-year | 4 | 17.75 | 5.25 | 1.88 | ||||
Left | Preoperative | 4 | 20.00 | 6.06 | 5.38 | 17.368 | 5 | 0.004 |
Postoperative 1-wk | 4 | 19.75 | 6.02 | 5.00 | ||||
Postoperative 1-month | 4 | 19.50 | 6.35 | 4.25 | ||||
Postoperative 2-month | 4 | 18.25 | 5.74 | 2.63 | ||||
Postoperative 4-month | 4 | 17.75 | 5.25 | 1.88 | ||||
Postoperative 1-year | 4 | 17.75 | 5.25 | 1.88 |
- Citation: Boyalı O, Kabatas S, Civelek E, Ozdemir O, Bahar-Ozdemir Y, Kaplan N, Savrunlu EC, Karaöz E. Allogeneic mesenchymal stem cells may be a viable treatment modality in cerebral palsy. World J Clin Cases 2024; 12(9): 1585-1596
- URL: https://www.wjgnet.com/2307-8960/full/v12/i9/1585.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i9.1585